Patel Sanj K's Form 4 filing
Kiniksa Pharmaceuticals International, plc (KNSA) · filed May 1, 2026
- Accession no.
- 0001532218-26-000008
- Filed
- May 1, 2026
- Trade date
- May 1, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.62M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Patel Sanj KCIK 0001532218 | Director, Officer (CHAIRMAN & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 1, 2026 | Class A Ordinary Share | MOption exerciseAcquired | +48,565 | $30.93 | +$1,502,115.45 | 48,565 | Direct | |
| May 1, 2026 | Class A Ordinary Share | SSaleDisposed | −48,565 | $54.02 | −$2,623,481.3 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 1, 2026 | Class A Ordinary Share | MOption exerciseDisposed | −48,565 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.